MedTrace Logo

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

NCT01511393 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 6750

Last updated 2023-06-13

No results posted yet for this study

Summary

This study is conducted in the United States of America (USA). The aim of the study is to monitor the number of annual new adult cases of medullary thyroid carcinoma (MTC) and to establish a registry for these new cases in order to identify any possible increase related to the introduction of liraglutide, exenatide once-weekly, and other GLP-1 receptor agonists into the US market.

Conditions

Interventions

OTHER

No treatment given

None. Non-interventional study.

Sponsors & Collaborators

Principal Investigators

  • Annette Stemhagen, DrPH, FISPE · United BioSource, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2039-12-31
Completion
2039-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01511393 on ClinicalTrials.gov